Bulletin de Périodique
International Journal of Drug Policy , Vol.120 - October 2023
Paru le :
01/10/2023
Année :
2023
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- Applying a mutual capacity building model to inform peer provider programs in South Africa and the United States: A combined qualitative analysis. Jack H.E., Anvari M.S., Abidogun T.M., Ochieng Y.A., Ciya N., Ndamase S., et al., art. 104144.
- The effects of race and class on community-level stigmatization of opioid use and policy preferences. Chavanne D., Ahluwalia J.S., Goodyear K., art. 104147.
- In our responses to the overdose epidemic, we cannot forget pregnant and postpartum people. West B.S., Choi S., Terplan M., art. 104153.
- Xylazine in the drug supply: Emerging threats and lessons learned in areas with high levels of adulteration. Quijano T., Crowell J., Eggert K., Clark K., Alexander M., Grau L., et al., art. 104154.
- Challenges of implementing safer supply programs in Canada during the COVID-19 pandemic: A qualitative analysis. Karamouzian M., Rafat B., Kolla G., Urbanoski K., Atkinson K., Bardwell G., et al., art. 104157.
- Use of safer smoking facilities within a supervised consumption service shaped by socio-structural factors: A qualitative study. Pijl E., Oosterbroek T., Dirk B., Mason E., art. 104158.
- A multicomponent holistic care pathway for people who use drugs in Tayside, Scotland. Byrne C.J., Radley A., Fletcher E., Thain D., Stephens B.P., Dillon J.F., art. 104159.
- The police paradox: A qualitative study of post-overdose outreach program implementation through public health-public safety partnerships in Massachusetts. Carroll J.J., Cummins E.R., Formica S.W., Green T.C., Bagley S.M., Beletsky L., et al., art. 104160.
- Buprenorphine deregulation as an opioid crisis policy response - A comparative analysis between France and the United States. Sud A., Chiu K., Friedman J., Dupouy J., art. 104161.
- The public as infrastructure in policy processes: The case of the abolition of the Swedish alcohol rationing system. Winter K., Edman J., art. 104162.
- Characteristics of post-overdose outreach programs and municipal-level opioid overdose in Massachusetts. Kimmel S.D., Xuan Z., Yan S., Lambert A.M., Formica S.W., Green T.C., et al., art. 104164.
- The social organization of opioid policies and their implications for people with chronic pain and clinicians: An institutional ethnography. Comer L., art. 104173.
- The benefits and challenges of virtual SMART recovery mutual-help groups: Participant and facilitator perspectives. Beck A.K., Waks S., Argent A., Deane F.P., Larance B., Manning V., et al., art. 104174.
- Caring for coca, living with chemicals: Towards ecological harm reduction. Rhodes T., Ordonez L.S., Acero C., Harris M., Holland A., Sanin F.G., art. 104179.
- Experiences of peer work in drug use service settings: A systematic review of qualitative evidence. Chen Y., Yuan Y., Reed B.G., art. 104182.
- Strategies for addressing needle debris: A scoping review of needle debris and discarded drug paraphernalia associated with substance use. Tung M., Jackson J., Ferreira C., Alix Hayden K., Ens T., art. 104183.
- Preferred stimulant safer supply and associations with methamphetamine preference among people who use stimulants in British Columbia: Findings from a 2021 cross-sectional survey. Ferguson M., Sedgemore K.-o., Scow M., Choisil P., Haywood B., Xavier J., et al., art. 104186.
- Long-term patterns of treatment use for opioid use disorder (OUD): Findings from the 18-20-year Australian Treatment Outcome Study. Wilson J., Mills K.L., Sunderland M., Freeman T.P., Keaveny M., Haasnoot K., et al., art. 104187.
- Xylazine in the drug supply: A research agenda. Harvey L.H., Green T.C., Park J.N., Rich J.D., art. 104190.
- Emerging adult perceptions of cannabis consumption: Examining changes in perceptions from pre-legalization to post-legalization. Harris-Lane L.M., Storey D.P., Drakes D.H., Donnan J.R., Bishop L.D., Harris N., art. 104193.
- Applying a mutual capacity building model to inform peer provider programs in South Africa and the United States: A combined qualitative analysis. Jack H.E., Anvari M.S., Abidogun T.M., Ochieng Y.A., Ciya N., Ndamase S., et al., art. 104144.
- The effects of race and class on community-level stigmatization of opioid use and policy preferences. Chavanne D., Ahluwalia J.S., Goodyear K., art. 104147.
- In our responses to the overdose epidemic, we cannot forget pregnant and postpartum people. West B.S., Choi S., Terplan M., art. 104153.
- Xylazine in the drug supply: Emerging threats and lessons learned in areas with high levels of adulteration. Quijano T., Crowell J., Eggert K., Clark K., Alexander M., Grau L., et al., art. 104154.
- Challenges of implementing safer supply programs in Canada during the COVID-19 pandemic: A qualitative analysis. Karamouzian M., Rafat B., Kolla G., Urbanoski K., Atkinson K., Bardwell G., et al., art. 104157.
- Use of safer smoking facilities within a supervised consumption service shaped by socio-structural factors: A qualitative study. Pijl E., Oosterbroek T., Dirk B., Mason E., art. 104158.
- A multicomponent holistic care pathway for people who use drugs in Tayside, Scotland. Byrne C.J., Radley A., Fletcher E., Thain D., Stephens B.P., Dillon J.F., art. 104159.
- The police paradox: A qualitative study of post-overdose outreach program implementation through public health-public safety partnerships in Massachusetts. Carroll J.J., Cummins E.R., Formica S.W., Green T.C., Bagley S.M., Beletsky L., et al., art. 104160.
- Buprenorphine deregulation as an opioid crisis policy response - A comparative analysis between France and the United States. Sud A., Chiu K., Friedman J., Dupouy J., art. 104161.
- The public as infrastructure in policy processes: The case of the abolition of the Swedish alcohol rationing system. Winter K., Edman J., art. 104162.
- Characteristics of post-overdose outreach programs and municipal-level opioid overdose in Massachusetts. Kimmel S.D., Xuan Z., Yan S., Lambert A.M., Formica S.W., Green T.C., et al., art. 104164.
- The social organization of opioid policies and their implications for people with chronic pain and clinicians: An institutional ethnography. Comer L., art. 104173.
- The benefits and challenges of virtual SMART recovery mutual-help groups: Participant and facilitator perspectives. Beck A.K., Waks S., Argent A., Deane F.P., Larance B., Manning V., et al., art. 104174.
- Caring for coca, living with chemicals: Towards ecological harm reduction. Rhodes T., Ordonez L.S., Acero C., Harris M., Holland A., Sanin F.G., art. 104179.
- Experiences of peer work in drug use service settings: A systematic review of qualitative evidence. Chen Y., Yuan Y., Reed B.G., art. 104182.
- Strategies for addressing needle debris: A scoping review of needle debris and discarded drug paraphernalia associated with substance use. Tung M., Jackson J., Ferreira C., Alix Hayden K., Ens T., art. 104183.
- Preferred stimulant safer supply and associations with methamphetamine preference among people who use stimulants in British Columbia: Findings from a 2021 cross-sectional survey. Ferguson M., Sedgemore K.-o., Scow M., Choisil P., Haywood B., Xavier J., et al., art. 104186.
- Long-term patterns of treatment use for opioid use disorder (OUD): Findings from the 18-20-year Australian Treatment Outcome Study. Wilson J., Mills K.L., Sunderland M., Freeman T.P., Keaveny M., Haasnoot K., et al., art. 104187.
- Xylazine in the drug supply: A research agenda. Harvey L.H., Green T.C., Park J.N., Rich J.D., art. 104190.
- Emerging adult perceptions of cannabis consumption: Examining changes in perceptions from pre-legalization to post-legalization. Harris-Lane L.M., Storey D.P., Drakes D.H., Donnan J.R., Bishop L.D., Harris N., art. 104193.
Cote :
Abonnement
Dépouillements
Ajouter le résultat à votre sélection
A. SUD ;
K. CHIU ;
J. FRIEDMAN ;
J. DUPOUY
|
2023
Dans International Journal of Drug Policy (Vol.120, October 2023) Article : Périodique
Dans International Journal of Drug Policy (Vol.120, October 2023) Article : Périodique
Background: In passing the Maintstreaming Addiction Treatment Act, the United States has abolished its federal X waiver, considered a major barrier to the wider buprenorphine prescribing needed to respond to opioid-related harms. Advocates for t[...]